Advertisement
Document › Details
Intellegens Ltd.. (3/9/23). "Press Release: Intellegens Celebrates Milestone Opening of New Cambridge Headquarters". Cambridge.
Region | Cambridge, Cambridgeshire | |
Country | United Kingdom (GB) | |
Organisation | Intellegens Ltd. | |
Product | business park management / science park management | |
Product 2 | Alchemite™ technology (AI) | |
Person | Pellegrini, Benjamin (Ben) (Intellegens 201701– CEO + Co-Founder) | |
Machine learning experts Intellegens today opened a new headquarters facility at Chesterton Mill, Cambridge, marking a major milestone in the growth of the company. Intellegens technology is applied to speed the development of products from aerospace alloys to whipping cream by providing scientists with deep insights into their experimental and process data.
A spin-off from the work of co-founder Dr Gareth Conduit and his colleagues in the University of Cambridge’s Cavendish laboratory, Intellegens has been located in the Barclays Eagle Labs incubator in Cambridge since 2018. Over this period, the company has developed a mature commercial software product, built a global base of customer organisations, and grown to nearly thirty employees. The new office will accommodate this team, with room for further growth, and provide a dedicated space in which the company can more easily develop its products and services in support of its customers.
Intellegens solves complex industrial R&D problems in chemicals, materials, manufacturing, and life sciences. Scientists who seek ideal combinations of many possible raw materials, ingredients, or processing steps often rely on large-scale, costly, time-consuming experimental programmes. The Intellegens software, Alchemite™, applies machine learning methods to learn from the data that these teams have collected, finding useful relationships and applying this information to predict the behaviour of new products and guide which experiments to do next. The result: better products with up to 90% less experimental cost. Alchemite™ works even where data has many gaps or errors. This scenario, typical of real-world data, usually causes machine learning approaches to fail.
There are now many examples of the successful application of the Alchemite™ method.
> Rolls-Royce were able to design a new aerospace alloy.
> Domino Printing Sciences speeded up the development of ink formulations.
> Johnson Matthey has optimised automotive catalysts for clean air applications.
> NASA validated the technology for use in material and component design.
> Global food producer Yili developed improved whipping cream formulations.
> AstraZeneca and Optibrium predicted key pharmacokinetic properties for drugs.
Intellegens co-founder and CEO Ben Pellegrini comments: “The move to our own dedicated facility at Chesterton Mill is a great milestone for Intellegens as we grow our business to support more customers in developing cleaner, more cost-effective, better products. We’d like to thank the team at Eagle Labs in Cambridge for their support on our journey from a start-up to a scale-up business. We’re already settling in to our new surroundings and we know this will provide a great environment for current and future employees to enjoy their work and develop their careers.”
About Chesterton Mill
Chesterton Mill, located between the Cambridge’s famous Science Park and its historic city centre, describes itself as “an urban oasis… where a diverse collection of historic buildings have been re-purposed around the Grade II listed windmill to create a dynamic workplace community unlike any other in Cambridge.” www.chestertonmill.com
See also:
Report in the Cambridge Independent business section
Supporting images
Click for larger images.
Intellegens HQ location at Chesterton Mill Cambridge
Chesterton Mill site (image courtesy of Savills).
Intellegens board member Graham Snudden cuts the ribbon at the office opening together with CEO Ben Pellegrini
Intellegens board member Graham Snudden cuts the ribbon at the office opening with CEO Ben Pellegrini
Dashboard view of Alchemite™ analytics for a formulation experimental programme
The Alchemite™ Analytics machine learning software.
Record changed: 2024-01-20 |
Advertisement
More documents for Intellegens Ltd.
- [1] Intellegens Ltd.. (8/30/23). "Press Release: Intellegens and CPI Awarded £1.6m Innovate UK Grant to Advance Manufacture of Oligonucleotide Therapeutics with Machine Learning". Cambridge....
- [2] Intellegens Ltd.. (4/11/22). "Press Release: Predicting Pharmacokinetics with Optibrium and AstraZeneca"....
- [3] Intellegens Ltd.. (3/24/22). "Press Release: Intellegens Announces Expansion"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top